Respiratory syncytial virus (RSV) is a highly contagious, viral infection affecting the respiratory system, primarily targeting infants, young children, and the elderly, causing symptoms ranging from common cold to severe bronchiolitis and pneumonia.
Hyperbaric oxygen therapy may enhance the immune system’s ability to combat respiratory syncytial virus by increasing oxygen levels, potentially reducing inflammation and protecting lung function.